Targeted proteomics for validation of biomarkers in clinical samples
about
Genomic and oncoproteomic advances in detection and treatment of colorectal cancerPlasmodium falciparum malaria: proteomic studiesInternal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry.Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface.Analysis of the formalin-fixed paraffin-embedded tissue proteome: pitfalls, challenges, and future prospectives.Using an isolated rat kidney model to identify kidney origin proteins in urine.Standardization and omics science: technical and social dimensions are inseparable and demand symmetrical studyAssessment of tandem mass spectrometry and high-resolution mass spectrometry for the analysis of bupivacaine in plasma.Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.Closing the gap between brain banks and proteomics to advance the study of neurodegenerative diseases.Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers.Industrialized MS-based proteomics in the search for circulating biomarkers.Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.Modeling and systematic analysis of biomarker validation using selected reaction monitoring.In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers.Proteogenomics for the Comprehensive Analysis of Human Cellular and Serum Antibody Repertoires.A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification.Laboratory Medicine in the Scope of Proteomics and Genomics
P2860
Q33425477-F491DB7B-91D5-4D8F-BF69-61602D090FFDQ33653123-35D8624B-B068-498F-8F80-0362A6B75FCAQ34310103-56E05B30-F430-43CD-A5ED-7C8DD0643E5CQ34551781-617C93CE-8B8B-4EBA-B0C4-1441DADCF379Q34671360-06A45BF2-AA37-4030-95BB-6D9136F8B63AQ34794421-04576573-3E6C-405D-B6C9-32455BAF0256Q35082733-55D75951-554D-4C08-8603-71C4E945921EQ35627328-324C5434-77C8-456B-BB58-849BAC3FFE26Q35798976-93704A2D-9147-49EA-8B17-5EAD5DAC0E25Q36284919-DDE33CC5-A59E-4D30-9406-EA95EE76C2BBQ37727199-128E4E45-D675-40AA-A957-BEA65ACAA8DBQ37810154-166BD396-5053-4A0F-9D22-B88658BE937EQ38068925-8F9E865B-0FB0-4CF3-A6E5-AD2A87620CFCQ38393985-CA1E6C1C-FF20-415F-9F9A-9BE972EA30C3Q38937624-BA86542F-3BE8-40E7-BD6A-F56417189003Q38968219-DE29ACFB-2CE0-4861-ABF1-0985897C8DF9Q41455489-3E2FFBA3-9B9D-4DCD-8E40-AF334D5ECB22Q42378646-4E3F1EFC-6A96-420F-8ACB-4C8E828F83D1
P2860
Targeted proteomics for validation of biomarkers in clinical samples
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted proteomics for validation of biomarkers in clinical samples
@en
Targeted proteomics for validation of biomarkers in clinical samples.
@nl
type
label
Targeted proteomics for validation of biomarkers in clinical samples
@en
Targeted proteomics for validation of biomarkers in clinical samples.
@nl
prefLabel
Targeted proteomics for validation of biomarkers in clinical samples
@en
Targeted proteomics for validation of biomarkers in clinical samples.
@nl
P2093
P2860
P356
P1476
Targeted proteomics for validation of biomarkers in clinical samples
@en
P2093
Josip Blonder
Timothy D Veenstra
Xiaoying Ye
P2860
P304
P356
10.1093/BFGP/ELN050
P577
2008-12-24T00:00:00Z